Studies on spasmogenic and spasmolytic sctivities of Calendula officinalis flowers

Phytotherapy Research

Volumn 20, Issue 10, 2006, Pages 906-910

  Bashir, Samra ^a,b   Janbaz, Khalid H ^b   Jabeen, Qaiser ^a   Gilani, Anwar Hassan ^a  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

Calcium antagonist; Calendula officinalis; Cholinergic; Guinea pig ileum; Rabbit jejunum; Spasmogenic; Spasmolytic

Indexed keywords

ALCOHOL; ATROPINE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CALENDULA EXTRACT; CHOLINERGIC RECEPTOR BLOCKING AGENT; POTASSIUM; SPASMOGEN; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; FLOWER; FRACTIONATION; JEJUNUM; MARIGOLD; MUSCLE CONTRACTION; MUSCLE RELAXATION; NONHUMAN; RABBIT; REPRODUCIBILITY;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALENDULA; CHEMICAL FRACTIONATION; CHOLINERGIC AGENTS; FLOWERS; GUINEA PIGS; ILEUM; JEJUNUM; PARASYMPATHOLYTICS; PLANT EXTRACTS; RABBITS;

CALENDULA OFFICINALIS; CAVIA PORCELLUS; ORYCTOLAGUS CUNICULUS;

EID: 33750213095     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1980     Document Type: Article

References (38)

1. Abasova RL, Aslanov SM, Mamedova ME. 1995. Amino acids of Calendula officinalis. Chem Nat Comp 30: 641.
2. Baquar SR. 1989. Medicinal and Poisonous Plants of Pakistan. Printas: Karachi, 73.
3. Bolton TB. 1979. Mechanism of action of transmitters and other substances on smooth muscles. Physiol Rev 59: 606-718.
4. Boucaud-Maitre Y, Algernon O, Raynaud J. 1988. Cytotoxic and anti tumoral activity of Calendula officinalis extracts. Pharmazie 43: 220-221.
5. Brading AF. 1981. How do drugs initiate contractions in smooth muscles. Trends Pharmacol Sci 2: 261-265.
6. Brown JH, Taylor P. 1996. Muscarinic receptor agonists and antagonists. In Goodman and Gillman's The Pharmacological Basis of Therapeutics, 9th edn, Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds). McGraw-Hill: New York, 141-159.
7. Brunton LL. 1996. Agents effecting gastrointestinal water flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes. In Goodman and Gillman's The Pharmacological Basis of Therapeutics, 9th edn, Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds). McGraw-Hill: New York, 917-936.
8. Chalchat JC, Garry RP, Michet A. 1991. Chemical composition of essential oil of Calendula officinalis L. Flavor Fragr J 6: 189-192.
9. Cordova CA, Siqueira IR, Netto CA et al. 2002. Protective properties of butanolic extract of the Calendula officinalis L. (marigold) against lipid peroxidation of rat liver microsomes and action as free radical scavenger. Redox Rep 7: 95-102.
10. Della Loggia RD, Sosa S, Leitner Z, Isaac O, Tubaro A. 1991. Anti-inflammatory activity of Calendula seed oil, rich in ω-6 fatty acids. Planta Med 57: A49.
11. Duke JA. 1992. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants. CRC Press: Tokyo, 117-118.
12. Duke JA, Bogenschutz-Godwin MJ, Du celliar J, Duke PAK. 2002. Hand Book of Medicinal Herbs, 2nd edn. CRC Press: Boca Raton, 139-140.
13. Elias R, De Meo M, Vidal-Ollivier E, Larget M, Balansard G, Dumenil G. 1990. Antimutagenic activity of some saponins isolated from Calendula officinalis L., C. arvensis L. and Hedera helix L. Mutagenesis 5: 327-331.
14. ++ antagonists. Gen Pharmacol 22: 177-181.
15. ++ in myocardium, cardiac pacemakers and vascular smooth muscle. Rev Pharmacol Toxicol 17: 149-166.
16. Fuchs SM, Schliemann-Willers S, Fischer TW, Elsner P. 2005. Protective effects of different marigold (Calendula officinalis L.) and rosemary cream preparations against sodium-lauryl-sulfate-induced irritant contact dermatitis. Skin Pharmacol Physiol 18: 195-200.
17. Gilani AH, Aftab K. 1992. Presence of acetylcholine like substance(s) in Sesamum indicum. Arch Pharmacol Res 4: 3-6.
18. ++ channel blocking activity of Artemesia scoparia extract. Phytother Res 8: 161-165.
19. Gilani AH, Janbaz KH, Zaman M, Lateef A, Tariq SR, Ahmad HR. 1994b. Hypotensive and spasmolytic activities of crude extract of Cyperus scariosus. Arch Pharm Res 17: 145-149.
20. Gilani AH, Shah AJ, Ghayur MN, Majeed K. 2005. Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci 76: 13089-13105.
21. Godfraind T, Miller R, Wibo M. 1986. Calcium antagonism and calcium entry blockade. Pharmacol Rev 38: 321-416.
22. Gora J, Swiatek L, Kalemba D, Kurowska A. 1979. Chemical substances from inflorescences of Arnica montana L. and Calendula officinalis L. soluble in isopropyl myristate and propylenic glycol. Planta Med 36: 286-287.
23. Iatsyno AI, Belova LF, Lipkina GS, Sokolov SI, Trutneva EA. 1978. Pharmacology of calenduloside B, a new triterpene glycoside from the roots of Calendula officinalis. Farmakol Toksikol 41: 556-560.
24. Iauk L, Lo Bue AM, Milazzo I, Rapisarda A, Blandino G. 2003. Antibacterial activity of medicinal plant extracts against periodontopathic bacteria. Phytother Res 17: 599-604.
25. Kalvatchev Z, Walder R, Garzaro D. 1997. Anti-HIV activity of extracts from Calendula officinalis flowers. Biomed Pharmacother 51: 176-180.
26. Karaki H, Weiss G. 1983. Mini review: calcium release in smooth muscles. Life Sci 42: 111-122.
27. Klouchek-Popova E, Popova A, Pavlova N, Krusteva S. 1982. Influence of the physiological regeneration and epithelialization using fractions isolated from Calendula officinalis. Acta Physiol Pharmacol Bulg 8: 63-67.
28. Marczal G, Cserjesi Z, Hethelyi E, Petri G. 1987. Data on the essential oil content and composition of Calendula officinalis L. Herb Hung 26: 179-189.
29. Nadkarni KM. 1976. Indian Materia Medica, 3rd edn. Popular Prakashan: Bombay, 234.
30. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC, 1-7.
31. Neukirch H, D' Ambrosio M, Dalla Via J, Guerriero A. 2004. Simultaneous quantitative determination of eight triterpenoid monoesters from flowers of 10 varieties of Calendula officinalis L. and characterisation of a new triterpenoid monoester. Phytochem Anal 15: 30-35.
32. Peyroux J, Rossignol P, Delaveau P. 1981. Anti-oedema and antihyperaemic properties of Calendula officinalis L. Plant Med Phytother 15: 210-216.
33. Tarle D, Dvorzak I. 1989. Antimicrobial substances in Flos Calendulae. Farm Vestn 40: 117-120.
34. Triggle DJ. 1992. Drugs affecting calcium-regulation and actions. In Text Book of Pharmacology, Smith GM, Reynard AM (eds). W. B. Saunders Co: Philadelphia, 453-479.
35. Tyler VE. 1993. The Honest Herbal, 3rd edn. The Haworth Press: Binghamton: New York, 75-76.
36. Van-Rossum JM. 1963. Cumulative dose-response curves. II. Techniques for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 143: 299-230.
37. Wagner H, Proksch A, Riess-Maurer I et al. 1984. Immunostimulating polysaccharides (heteroglycanes) of higher plants. Preliminary communication. Arzneimittelforsch 34: 659-661.
38. Yoshikawa M, Murakami T, Kishi A, Kageura T, Matsuda H. 2001. Medicinal flowers. III. Marigold. (1): hypoglycemic, gastric emptying inhibitory, and gastroprotective principles and new oleanane-type triterpene oligoglycosides, calendasaponons A, B, C, and D, from Egyptian Calendula officinalis. Chem Pharm Bull 49: 863-870.